Jingjun Zhou

发表

Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell‐derived cardiomyocytes with a MYBPC3 mutation

G. Fu, Tingyu Gong, Yaxun Sun, 2021, Clinical and translational medicine.

The Immunomodulatory Properties of Mesenchymal Stem Cells Play a Critical Role in Inducing Immune Tolerance after Liver Transplantation

Shao-wei Li, Xian-Bin Zhou, Xinli Mao, 2021, Stem cells international.

Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.

T. Niu, Z. Meng, L. Tang, 2020, Journal of molecular and cellular cardiology.

Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation.

Tingyu Gong, Yaxun Sun, C. Jiang, 2022, Stem cell research.

Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes

Junnan Zheng, Tingyu Gong, Yaxun Sun, 2023, Stem Cell Research & Therapy.

Hyperactivation of platelet‐derived growth factor signalling contributes to arrhythmogenesis in Brugada syndrome

Luyang Yu, Fan Yang, M. Qi, 2022, Clinical and translational medicine.

Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome

Tingyu Gong, Yaxun Sun, Jun Su, 2023, Stem Cell Research & Therapy.

Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.

Tingyu Gong, Yaxun Sun, C. Jiang, 2022, Stem cell research.

Lamin A/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model

Tingyu Gong, Hao Wang, Jiaxi Shen, 2024, Nature communications.

Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.

Tingyu Gong, Yaxun Sun, Hao Wang, 2022, Stem cell research.